Amryt Pharma Plc - ADR

-0.07 (-0.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)421.56M
Current PEN/A
Forward PE N/A
2yr Forward PE 14.87
See more stats
Estimates Current Quarter
Revenue$51.53 Million
Adjusted EPS-$0.15
See more estimates
10-Day MA$11.74
50-Day MA$12.19
200-Day MA$13.07
See more pivots

Amryt Pharma Plc - ADR Stock, NASDAQ:AMYT

45 Mespil Road, Fitzwilliam Hall, Dublin, Dublin 4
Phone: +353.1.1518.0200
Number of Employees:


Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. It operates through the Pharmaceutical segment, which is focused on the development and commercialization of commercial and development products. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded by Joseph Amrit Wiley and Rory Peter Nealon on August 28, 2015 and is headquartered in Dublin, Ireland.